Volume 27, Number 3—March 2021
Research
Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014–2017
Table 1
Clustered isolates, n = 281 | DR TB types, no. (%)† |
|||
---|---|---|---|---|
INH-R, n = 11 | MDR TB, n = 205 | Pre-XDR TB, n = 46 | XDR TB, n = 19 | |
Possible primary DR TB,‡ n = 230, 81.85% | 11 (100.0) | 176 (85.85) | 29 (63.04) | 14 (73.68) |
Possible acquired DR TB,‡ n = 51, 18.15% | 0 | 29 (14.15) | 17 (36.96) | 5 (26.32) |
*Using a pairwise-difference range of 0–11 single nucleotide polymorphisms, 89 clusters (minimum cluster size = 2 isolates) were recognized. DR, drug-resistant; INH-R, isoniazid resistant; MDR, multidrug-resistant; TB, tuberculosis; XDR, extensively drug-resistant. †DR TB types based on genotypic drug susceptibility tests. ‡Possible primary DR TB isolates were differentiated from acquired DR TB isolates based on the acquisition of mutations associated with DR TB and from co-ancestral relationships.
Page created: December 29, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.